anvajo
anvajo is a German #healthtech scaleup that has developed the world’s most compact point-of-care testing solution for fluid analysis, the “fluidlab”. After successful application of the solution in animal healthcare, anvajo is now scaling up further to prepare for the implementation of the solution in human healthcare, providing a world of opportunities across different areas of diagnostics.
Last week, anvajo successfully closed a Series A funding round of €17.7m, led by German pharmaceutical company MEDICE Arzneimittel Pütter GmbH & Co. KG and with participations from both German and US investors, to support them on this journey. We at Park 56 would like to congratulate the anvajo team on this great step and we are proud to have advised you on this process. Thank you Felix Lambrecht, Stefan Fraedrich and Harm van Maanen for your trust and for the great teamwork!